Search research articles
Contact Us
Filters
Showing results (11-20 of 21) with videos related to
Page
of 3
Sort By:
Molecules (Basel, Switzerland)
|
April 19, 2017
One-Pot Phosphate-Mediated Synthesis of Novel 1,3,5-Trisubstituted Pyridinium Salts: A New Family of S. aureus Inhibitors
Thomas Pesnot, Markus C Gershater, Martin Edwards, et al.
Organic & Biomolecular Chemistry
|
August 16, 2013
Exploring the role of the 5-substituent for the intrinsic fluorescence of 5-aryl and 5-heteroaryl uracil nucleotides: a systematic study
Thomas Pesnot, Lauren M Tedaldi, Pablo G Jambrina, et al.
Biochemistry
|
September 16, 2017
Structural Evidence for the Dopamine-First Mechanism of Norcoclaurine Synthase
Benjamin R Lichman, Altin Sula, Thomas Pesnot, et al.
Journal of Medicinal Chemistry
|
February 24, 2012
Inhibition of galactosyltransferases by a novel class of donor analogues
Karine Descroix, Thomas Pesnot, Yayoi Yoshimura, et al.
Journal of Medicinal Chemistry
|
May 3, 2011
Two-step synthesis of novel, bioactive derivatives of the ubiquitous cofactor nicotinamide adenine dinucleotide (NAD)
Thomas Pesnot, Julia Kempter, Jörg Schemies, et al.
The FEBS Journal
|
January 27, 2015
'Dopamine-first' mechanism enables the rational engineering of the norcoclaurine synthase aldehyde activity profile
Benjamin R Lichman, Markus C Gershater, Eleanor D Lamming, et al.
Bioorganic & Medicinal Chemistry Letters
|
August 18, 2020
Novel C-7 carbon substituted fourth generation fluoroquinolones targeting N. Gonorrhoeae infections
Ralph Kirk, Mark Betson, Matilda Bingham, et al.
Carbohydrate Research
|
February 10, 2015
Enzymatic synthesis of nucleobase-modified UDP-sugars: scope and limitations
Ben A Wagstaff, Martin Rejzek, Thomas Pesnot, et al.
Chemmedchem
|
February 19, 2024
Accelerating BRPF1b hit identification with BioPhysical and Active Learning Screening (BioPALS)
Sandeep Pal, Zandile Nare, Vincenzo A Rao, et al.
Bioorganic & Medicinal Chemistry
|
December 3, 2014
2- and 3-substituted imidazo[1,2-a]pyrazines as inhibitors of bacterial type IV secretion
James R Sayer, Karin Walldén, Thomas Pesnot, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 21) with videos related to
Sort By:
Page
of 3
Molecules (Basel, Switzerland)
|
April 19, 2017
One-Pot Phosphate-Mediated Synthesis of Novel 1,3,5-Trisubstituted Pyridinium Salts: A New Family of S. aureus Inhibitors
Thomas Pesnot, Markus C Gershater, Martin Edwards, et al.
Organic & Biomolecular Chemistry
|
August 16, 2013
Exploring the role of the 5-substituent for the intrinsic fluorescence of 5-aryl and 5-heteroaryl uracil nucleotides: a systematic study
Thomas Pesnot, Lauren M Tedaldi, Pablo G Jambrina, et al.
Biochemistry
|
September 16, 2017
Structural Evidence for the Dopamine-First Mechanism of Norcoclaurine Synthase
Benjamin R Lichman, Altin Sula, Thomas Pesnot, et al.
Journal of Medicinal Chemistry
|
February 24, 2012
Inhibition of galactosyltransferases by a novel class of donor analogues
Karine Descroix, Thomas Pesnot, Yayoi Yoshimura, et al.
Journal of Medicinal Chemistry
|
May 3, 2011
Two-step synthesis of novel, bioactive derivatives of the ubiquitous cofactor nicotinamide adenine dinucleotide (NAD)
Thomas Pesnot, Julia Kempter, Jörg Schemies, et al.
The FEBS Journal
|
January 27, 2015
'Dopamine-first' mechanism enables the rational engineering of the norcoclaurine synthase aldehyde activity profile
Benjamin R Lichman, Markus C Gershater, Eleanor D Lamming, et al.
Bioorganic & Medicinal Chemistry Letters
|
August 18, 2020
Novel C-7 carbon substituted fourth generation fluoroquinolones targeting N. Gonorrhoeae infections
Ralph Kirk, Mark Betson, Matilda Bingham, et al.
Carbohydrate Research
|
February 10, 2015
Enzymatic synthesis of nucleobase-modified UDP-sugars: scope and limitations
Ben A Wagstaff, Martin Rejzek, Thomas Pesnot, et al.
Chemmedchem
|
February 19, 2024
Accelerating BRPF1b hit identification with BioPhysical and Active Learning Screening (BioPALS)
Sandeep Pal, Zandile Nare, Vincenzo A Rao, et al.
Bioorganic & Medicinal Chemistry
|
December 3, 2014
2- and 3-substituted imidazo[1,2-a]pyrazines as inhibitors of bacterial type IV secretion
James R Sayer, Karin Walldén, Thomas Pesnot, et al.
Page
of 3